MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q1 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $308,000 | +5.1% | 9,542 | -0.5% | 0.00% | – |
| Q2 2021 | $293,000 | +12.7% | 9,594 | -47.2% | 0.00% | – |
| Q1 2020 | $260,000 | -36.7% | 18,155 | +20.2% | 0.00% | -100.0% |
| Q4 2019 | $411,000 | +30.5% | 15,106 | +59.1% | 0.00% | – |
| Q1 2019 | $315,000 | +43.2% | 9,493 | +25.4% | 0.00% | – |
| Q4 2018 | $220,000 | -30.8% | 7,570 | +9.4% | 0.00% | – |
| Q3 2018 | $318,000 | +46.5% | 6,919 | +9.3% | 0.00% | – |
| Q4 2017 | $217,000 | -34.0% | 6,331 | -30.4% | 0.00% | -100.0% |
| Q3 2017 | $329,000 | -4.9% | 9,097 | -10.6% | 0.00% | -50.0% |
| Q4 2014 | $346,000 | -11.3% | 10,173 | +0.7% | 0.00% | 0.0% |
| Q3 2014 | $390,000 | -66.1% | 10,107 | -65.8% | 0.00% | -71.4% |
| Q2 2014 | $1,149,000 | +143.4% | 29,532 | +68.3% | 0.01% | +75.0% |
| Q2 2013 | $472,000 | – | 17,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,309,206 | $109,866,000 | 6.94% |
| SG Capital Management LLC | 604,159 | $20,058,000 | 3.66% |
| KESTREL INVESTMENT MANAGEMENT CORP | 232,975 | $7,735,000 | 3.57% |
| Broadfin Capital, LLC | 500,000 | $16,600,000 | 3.43% |
| Tieton Capital Management, LLC | 98,199 | $3,260,000 | 2.90% |
| SG Capital Management LLC | 350,000 | $11,620,000 | 2.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,852,064 | $94,689,000 | 1.66% |
| Broadfin Capital, LLC | 240,000 | $7,968,000 | 1.64% |
| Millrace Asset Group, Inc. | 58,302 | $1,936,000 | 1.63% |
| PURA VIDA INVESTMENTS, LLC | 300,000 | $9,960,000 | 1.42% |